#3 Increase Awareness and Reporting of Mental Health Symptoms A recent report , using qualitative and quantitative/mixed methods, social media listening, and AI and Natural Language Processing techniques, assesses GLP-1 RAs and perceived mental health issues by a large number of open web and social media platform customers
"We have a long history of successfully working with regulators, and look forward to continuing to engage with the FDA to ensure safe access to affordable healthcare." Novo Nordisk spokesperson Liz Skrbkova said in a statement, "We welcome today's actions by HHS and FDA to protect patients from unapproved knockoff drugs made with foreign inauthentic active pharmaceutical ingredients that can pose significant risks to patient safety." A Lilly spokesperson said the company applauded the FDA action
There have also been reports of diabetic retinopathy complications in patients with pre-existing retinal disease, necessitating appropriate monitoring and prompt reporting of visual changes
Media hype (the Hollywoods worst-kept secret, King Kong of weight loss, etc.) has spotlighted GLP-1 drugs, but the medical issue is delayed gastric emptying that, in some patients, is linked to gastroparesis-like symptoms
Study results A total of 195 participants (mean age 42.84 years
Many patients blame themselves for lack of discipline when the real issue is that their metabolism is underpowered